I like the look of this chart. I am giving you a nice 111.11% potential on this trading pair.
See a bullish crossover on the MACD
✔️ The MACD line (blue) crosses over the Signal line (orange) to the upside.
✔️ The candles 4-Mar. and 7-Mar. both represent reversal signals based on Candlestick reading.
✔️ Notice the falling wedge pattern as well and if we continue looking, we find more.
✔️ Elliot Wave Theory, we have the first and second waves, a third wave follows...
I think that's enough 😁.
Namaste.
See a bullish crossover on the MACD
✔️ The MACD line (blue) crosses over the Signal line (orange) to the upside.
✔️ The candles 4-Mar. and 7-Mar. both represent reversal signals based on Candlestick reading.
✔️ Notice the falling wedge pattern as well and if we continue looking, we find more.
✔️ Elliot Wave Theory, we have the first and second waves, a third wave follows...
I think that's enough 😁.
Namaste.
🚨 TOP FREE Trades
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 TOP FREE Trades
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.